Autoimmune hepatitis (AIH) in the elderly: A systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre

Journal of Hepatology

Volumn 45, Issue 4, 2006, Pages 575-583

  Al Chalabi, Thawab ^a   Boccato, Sylvia ^a   Portmann, Bernard C ^a   McFarlane, Ian G ^a   Heneghan, Michael A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Autoimmune hepatitis; Cirrhosis; Immunosenescence; Old age

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; PENICILLAMINE; PREDNISOLONE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; BASAL CELL CARCINOMA; BREAST CARCINOMA; CHILD; CLINICAL FEATURE; COLON CARCINOMA; CONTROLLED STUDY; CYTOPENIA; DISEASE COURSE; FEMALE; FOLLOW UP; HAPLOTYPE; HISTOLOGY; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MOON FACE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PHARYNX CARCINOMA; PRIORITY JOURNAL; PSYCHOSIS; RELAPSE; RETROSPECTIVE STUDY; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; TERTIARY HEALTH CARE; TREATMENT RESPONSE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ASCITES; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; MALE; MIDDLE AGED; RECURRENCE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33748116726     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.04.007     Document Type: Article

References (33)

1. Ludwig J., McFarlane I.G., and Rakela J. Terminology of chronic hepatitis. International Working Party. Am J Gastroenterol 90 (1995) 181-189
2. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
3. Heneghan M.A., and McFarlane I.G. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 35 (2002) 7-13
4. Donaldson P.T., Doherty D.G., Hayllar K.M., McFarlane I.G., Johnson P.J., and Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13 (1991) 701-706
5. Czaja A.J., and Donaldson P.T. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 174 (2000) 250-259
6. Donaldson P.T., and Czaja A.J. Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis. Clin Liver Dis 6 (2002) 419-437
7. Toda G., Zeniya M., Watanabe F., Imawari M., Kiyosawa K., Nishioka M., et al. Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol 26 (1997) 1207-1212
8. Reuben A. A sheep in wolf's clothing. Hepatology 38 (2003) 1596-1601
9. Lebovics E., Schaffner F., Klion F.M., and Simon C. Autoimmune chronic active hepatitis in postmenopausal women. Dig Dis Sci 30 (1985) 824-828
10. Parker D.R., and Kingham J.G. Type I autoimmune hepatitis is primarily a disease of later life. QJM 90 (1997) 289-296
11. Schramm C., Kanzler S., Meyer zum Buschenfelde K.H., Galle P.R., and Lohse A.W. Autoimmune hepatitis in the elderly. Am J Gastroenterol 96 (2001) 1587-1591
12. Yarze J.C., Meyer zum Buschenfelde K.-H., and Lohse A.W. Autoimmune hepatitis. N Engl J Med 334 (1996) 923-924
13. Selby C.D., and Toghill P.J. Chronic active hepatitis in the elderly. Age Ageing 15 (1986) 350-356
14. Newton J.L., Burt A.D., Park J.B., Mathew J., Bassendine M.F., and James O.F. Autoimmune hepatitis in older patients. Age Ageing 26 (1997) 441-444
15. Batts K.P., and Ludwig J. Chronic Hepatitis. An update on terminology and reporting. Am J Surg Pathol 19 (1995) 1409-1417
16. Johnson P.J., McFarlane I.G., and Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 333 (1995) 958-963
17. Johnson P.J., and McFarlane I.G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 18 (1993) 998-1005
18. Hilmer S.N., Cogger V.C., Fraser R., McLean A.J., Sullivan D., and Le Couteur D.G. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology 42 (2005) 1349-1354
19. Huet P.M., and Villenueve J.P. Microcirculation of the aging liver: is getting old like having cirrhosis?. Hepatology 42 (2005) 1248-1251
20. Czaja A.J., and Carpenter H.A. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology 39 (2004) 1631-1638
21. Hegarty J.E., Nouri Aria K.T., Portmann B., Eddleston A.L., and Williams R. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology 3 (1983) 685-689
22. Kanzler S., Gerken G., Lohr H., Galle P.R., Meyer zum Buschenfelde K.H., and Lohse A.W. Duration of immunosuppressive therapy in autoimmune hepatitis. J Hepatol 34 (2001) 354-355
23. Verslype C., George C., Buchel E., Nevens F., van Steenbergen W., and Fevery J. Diagnosis and treatment of autoimmune hepatitis at age 65 and older. Aliment Pharmacol Ther 21 (2005) 695-699
24. Collier J.D., Ninkovic M., and Compston J.E. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50 Suppl. 1 (2002) i1-i9
25. Ryder S.D., Koskinas J., Rizzi P.M., McFarlane I.G., Portmann B.L., Naoumov N.V., et al. Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus. Hepatology 22 (1995) 718-722
26. Fattovich G., Stroffolini T., Zagni I., and Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 (2004) S35-S50
27. Ryder S.D. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52 Suppl. 3 (2003) iii1-iii8
28. Soloway R.D., Summerskill W.H., Baggenstoss A.H., Geall M.G., Gitnick G.L., Elveback I.R., et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 63 (1972) 820-833
29. Kirk A.P., Jain S., Pocock S., Thomas H.C., and Sherlock S. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut 21 (1980) 78-83
30. Hakim F.T., Flomerfelt F.A., Boyiadzis M., and Gress R.E. Aging, immunity and cancer. Curr Opin Immunol 16 (2004) 151-156
31. Wang X., Kiyokawa H., Dennewitz M.B., and Costa R.H. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci USA 99 (2002) 16881-16886
32. Wang X., Krupczak-Hollis K., Tan Y., Dennewitz M.B., Adami G.R., and Costa R.H. Increased hepatic Forkhead Box M1B (FoxM1B) levels in old-aged mice stimulated liver regeneration through diminished p27Kip1 protein levels and increased Cdc25B expression. J Biol Chem 277 (2002) 44310-44316
33. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., and Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433 (2005) 760-764